Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05673915 · ClinicalTrials.gov registry record · NA

Study of Transcranial Direct Current Stimulation to Treat Epilepsy

A NA study of Focal Epilepsy and Generalized Onset Epilepsy, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05673915 is a NA study of Focal Epilepsy and Generalized Onset Epilepsy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 168-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05673915, a NA study of Focal Epilepsy and Generalized Onset Epilepsy, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.

Conditions Studied

Focal Epilepsy Generalized Onset Epilepsy Sleep-related Epileptic Encephalopathy

Interventions

  • DEVICE ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)
  • DEVICE ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)

Study Locations (1)

Minnesota

  • Mayo Clinic Minnesota - Rochester

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-04-12
Est. Completion 2026-12
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05673915

The ClinicalTrials.gov registry entry for NCT05673915 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 168-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (82% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Focal Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS) is the first listed.

NCT05673915 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05673915 about?

NCT05673915 is a clinical study titled "Study of Transcranial Direct Current Stimulation to Treat Epilepsy". The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.

What is the current status of trial NCT05673915?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-04-12. Estimated completion is 2026-12.

What conditions does trial NCT05673915 study?

This clinical trial studies the following conditions: Focal Epilepsy, Generalized Onset Epilepsy, Sleep-related Epileptic Encephalopathy.

What interventions are being tested in trial NCT05673915?

The interventions under investigation include: ActivaDose II 0.1 mA transcranial direct current stimulation (tDCS) (DEVICE), ActivaDose II 2.0 mA transcranial direct current stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT05673915?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05673915 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Focal Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Focal Epilepsy

All registered trials for this condition

Generalized Onset Epilepsy

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.